Written question asked by Baroness Brinton (Liberal Democrat) on Monday, 18 May 2020, in the House of Lords. It was due for an answer on Tuesday, 2 June 2020. It was answered by Lord Bethell (Conservative) on Wednesday, 3 June 2020 on behalf of the Department of Health and Social Care.
Coronavirus: Screening
- Question
-
To ask Her Majesty's Government when they first became aware of the Roche Elecsys Anti-SARS-CoV-2 antibody test; what discussions they held with the European Medicines Agency and stakeholders in Germany about their trials and approval processes; and why they decided to run their own separate trials and approval process.
- Answer
-
Public Health England (PHE) were asked to review all major suppliers of assays for National Health Service use, including the Roche Elecsys Anti-SARS-CoV-2 antibody test, in order to limit the amount of on-site evaluation each facility has to perform.
PHE is familiar with the processes involved in European Medicine Agency registration. No discussions have been held with stakeholders in Germany about their trial and approvals processes.
Secondary information
- Type
- Written question
- Reference
- HL4565
- Session
- 2019-21
- Subjects
- Screening Roche Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-07-21 10:33:35 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL4565
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL4565
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-21/HL4565